Real Endpoints brings a wide range of strategic and operational market access solutions to our clients.
News and Events
REPC Webinar: War Stories (the scars) of Budget Impact Modeling
Speaker: Dan Danielson, Pharmacy Manager, Premera BlueCross
Speaker: Dan Olendorf, Chief Scientific Officer, Institute for Clinical & Economic Review (ICER)
Moderator: Jane Barlow, EVP & Chief Clinical Officer, Real Endpoints
Adventures in over-, under-, and correctly estimating drug costs…and defining what’s worth the extra money.
January 17, 2018
Webinarrequest presentation >
by Emily Hayes
Labeling for reduction of cardiovascular risk may help a bit with payers, but the "twin problem" of pricing and lack of patient adherence is likely to continue to present hurdles for reimbursement.
December 1, 2017
by Ed Silverman
As controversy continues over pharmaceutical pricing, more drugmakers are eyeing deals that peg health plan cost to outcomes to boost volume and win formulary placement. But these deals are challenging to construct and to date there is little evidence that they reduce costs for patients.
November 20, 2017
In Vivonews >
Attendee: Real Endpoints Team
Over 700 leaders in Patient Access, Brand Management, Reimbursement and Specialty Distribution across the industry have benefited from CBI’s Hub and SPP Model Optimization conference series.
February 27, 2018
February 28, 2018
Philadelphia, PAevent >
Recent Insightsview archive >
February 20, 2018
Real Endpoints plays a valuable role in orchestrating a first-of-its-kind value-based contract between Harvard Pilgrim and Illumina by introducing the parties and helping to craft the deal structure. Real Endpoints will provide all analytics and financial reconciliation for the initiative.read full press release >
January 11, 2018
Roger Longman, CEO of Real Endpoints, a firm assisting pharma companies with their pricing strategies, discusses the state of the value-based pricing market while lending some insights on what specialty drug companies like Spark can do to get payers on board with higher prices.Listen to full insight podcast >
National Business Director
Top 5 Pharma
Specialty Access Solutions, Top 5 Pharma
Director of Operations
Reimbursement and Patient Support Services, Top 20 Pharma
Chronis H. Manolis, RPh
Vice President, Pharmacy UPMC Health Plan
President , GlaxoSmithKline U.S.